Structure Therapeutics, Inc. (GPCR)
41.64
+3.87
(+10.25%)
USD |
NASDAQ |
Jun 09, 16:00
41.25
-0.39
(-0.94%)
After-Hours: 20:00
Structure Therapeutics SG&A Expense (Quarterly) : 22.94M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 2.934B |
| Novo Nordisk A/S | 2.070B |
| Viking Therapeutics, Inc. | 13.98M |
| Pfizer Inc. | 2.961B |
| Tarsus Pharmaceuticals, Inc. | 136.43M |